Qualcomm Incorporated and Novartis launched drx Capital

Qualcomm Incorporated, through one of its affiliates, and Novartis launched dRx Capital AG, a Swiss based joint venture investment company, with a capital commitment up to $100 million. The joint venture will invest in early-stage companies leveraging the extensive networks in pharma, mobile/IT, and the investment community of the two JV owners.

Lenz & Staehelin advises Qualcomm in this matter. The team comprises partner Tino Gaberthüel and senior associate Dominik Kaczmarczyk.